Quest diagnostics reports third quarter 2023 financial results; updates guidance for full year 2023

Third quarter revenues of $2.30 billion, down 7.7% from 2022 third quarter reported diluted earnings per share ("eps") of $1.96, down 9.7% from 2022; and adjusted diluted eps of $2.22, down 5.9% from 2022 third quarter base business revenues of $2.27 billion, up 4.6% from 2022 full year 2023 revenues now expected to be between $9.19 billion and $9.24 billion; reported diluted eps now expected to be between $7.61 and $7.71; and adjusted diluted eps expected to be between $8.65 and $8.75 secaucus, n.j. , oct. 24, 2023 /prnewswire/ -- quest diagnostics incorporated (nyse: dgx), the world's leading provider of diagnostic information services, announced today financial results for the third quarter ended september 30, 2023.
DGX Ratings Summary
DGX Quant Ranking